Clinical Trial Update: Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis [Phase 4]

View source ↗

Summary

Clinical trial update about a Phase 4 study evaluating two weeks of low molecular weight heparin for distal vein thrombosis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Venous Thrombosis

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Monash Medical Centre | Conditions: Venous Thrombosis, Pulmonary Embolism | Phase 4 | Status: UNKNOWN